A novel, soluble homologue of the human IL-10 receptor with preferential expression in placenta

Genes and Immunity

Volumn 2, Issue 6, 2001, Pages 329-334

  Gruenberg, B H ^a   Schoenemeyer, A ^a   Weiss, B ^a   Toschi, L ^a   Kunz, S ^a   Wolk, K ^a   Asadullah, K ^a   Sabat, R ^a,b  

^a BAYER PHARMA AG   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Bioinformatic search; CRF2; IL 10 family; IL 22; Pregnancy; Soluble receptor

Indexed keywords

CYTOKINE RECEPTOR; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN RECEPTOR; MESSENGER RNA;

AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; ARTICLE; BIOLOGY; CHEMISTRY; CHROMOSOME 6; CHROMOSOME MAP; EXON; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENETIC DATABASE; GENETICS; HUMAN; INTRON; LEUKOCYTE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PLACENTA; SEQUENCE HOMOLOGY; SOLUBILITY;

AMINO ACID SEQUENCE; BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 6; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; EXONS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMANS; INTRONS; LEUKOCYTES; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; PHYSICAL CHROMOSOME MAPPING; PLACENTA; RECEPTORS, CYTOKINE; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-10; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; SOLUBILITY;

EID: 0035487081     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363786     Document Type: Article

References (34)

1. Gallagher G, Dickensheets H, Eskdale J et al. Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10). Genes Immun 2000; 1: 442-450.
2. Blumberg H, Conklin D, Xu WF et al. Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell 2001; 104: 9-19.
3. Dumoutier L, Louahed J, Renauld JC. Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J Immunol 2000; 164: 1814-1819.
4. Knappe A, Hor S, Wittmann S, Fickenscher H. Induction of a novel cellular homolog of interleukin-10, AK155, by transformation of T lymphocytes with herpesvirus saimiri. J Virol 2000; 74: 3881-3887.
5. Jiang H, Lin JJ, Su ZZ, Goldstein NI, Fisher PB. Subtraction hybridization identifies a novel melanoma differentiation associated gene, MDA-7, modulated during human melanoma differentiation, growth and progression. Oncogene 1995; 11: 2477-2486.
6. Dumoutier L, Van Roost E, Ameye G, Michaux L, Renauld JC. IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes. Genes Immun 2000; 1: 488-494.
7. Kotenko SV, Pestka S. Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes. Oncogene 2000; 19: 2557-2565.
8. Bazan JF. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 1990; 87: 6934-6938.
9. Ho AS, Liu Y, Khan TA, Hsu DH, Bazan JF, Moore KW. A receptor for interleukin 10 is related to interferon receptors. Proc Natl Acad Sci USA 1993; 90: 11267-11271.
10. Kotenko SV, Krause CD, Izotova LS, Pollack BP, Wu W, Pestka S. Identification and functional characterization of a second chain of the interleukin-10 receptor complex. EMBO 1997; 16: 5894-5903.
11. Finbloom DS, Winestock KD. IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. J Immunol 1995; 155: 1079-1090.
12. Dumoutier L, Van Roost E, Colau D, Renauld JC. Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc Natl Acad Sci USA 2000; 97: 10144-10149.
13. Xie MH, Aggarwal S, Ho WH et al. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J Biol Chem 2000; 275: 31335-31339.
14. Kotenko SV, Izotova LS, Mirochnitchenko OV et al. Identification of the functional IL-TIF (IL-22) receptor complex: the IL-10R2 chain (IL-10Rβ) is a shared component of both IL-10 and IL-TIF (IL-22) receptor complexes. J Biol Chem 2001; 276: 2725-2732.
15. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683-765.
16. Jiang H, Su ZZ, Lin JJ, Goldstein NI, Young CS, Fisher PB. The melanoma differentiation associated gene MDA-7 suppresses cancer cell growth. Proc Natl Acad Sci USA 1996; 93: 9160-9165.
17. Su ZZ, Madireddi MT, Lin JJ et al. The cancer growth suppressor gene MDA-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice. Proc Natl Acad Sci USA 1998; 95: 14400-14405.
18. Nielsen H, Engelbrecht J, Brunak S, von Heijne G. Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng 1997; 10: 1-6.
19. Hershey GK, Schreiber RD. Biosynthetic analysis of the human interferon-gamma receptor. Identification of N-linked glycosylation intermediates. J Biol Chem 1989; 264: 11981-11988.
20. Hoover DM, Schalk-Hihi C, Chou CC, Menon S, Wlodawer A, Zdanov A. Purification of receptor complexes of interleukin-10 stoichiometry and the importance of deglycosylation in their crystallization. Eur J Biochem 1999; 262: 134-141.
21. Dumoutier L, Lejeune D, Colau D, Renauld JC. Cloning and characterization of Interleukin-22 Binding Protein (IL-22BP), a natural antagonist of IL-TIF/IL-22. J Immunol 2001; 166: 7090-7095.
22. Kotenko SV, Izotova LS, Mirochnitchenko Ov et al. Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity. J Immunol 2001; 166: 7096-7103.
23. Fernandez-Botran R, Chilton PM, Ma Y. Soluble cytokine receptors: Their roles in immunoregulation, disease, and therapy. Adv Immunol 1996; 63: 269-336.
24. Heaney ML, Golde DW. Soluble receptors in human disease. J Leukoc Biol 1998; 64: 135-146.
25. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996; 87: 2095-2147.
26. Dinarello CA. Cytokines as endogenous pyrogens. J Infect Dis 1999; 179 (Suppl 2): 294-304.
27. Mohler KM, Torrance DS, Smith CA et al. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 1993; 151: 1548-1561.
28. Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol Today 1997; 18: 478-482.
29. Mellor AL, Munn DH. Immunology at the maternal-fetal interface: lessons for T cell tolerance and suppression. Annu Rev Immunol 2000; 18: 367-391.
30. Walter MR, Windsor WT, Nagabhushan TL et al. Crystal structure of a complex between interferon-gamma and its soluble high-affinity receptor. Nature 1995; 376: 230-235.
31. Zdanov A, Schalk-Hihi C, Wlodawer A. Crystal structure of human interleukin-10 at 1.6 A resolution and a model of a complex with its soluble receptor. Protein Sci 1996; 5: 1955-1962.
32. Reineke U, Sabat R, Volk HD, Schneider-Mergener J. Mapping of the interleukin-10/interleukin-10 receptor combining site. Protein Sci 1998; 7: 951-960.
33. Wolk K, Döcke W-D, von Baehr V, Volk H-D, Sabat R. Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 2000, 96: 218-223.
34. Asadullah K, Friedrich M, Hanneken S et al. Effects of systemic interleukin-10 therapy on psoriatic skin lesions: histologic, immunohistologic, and molecular biology findings. J Invest Dermatol 2001; 116: 721-727.